IBDEI1D7 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24180,0)
 ;;=573.4^^133^1472^12
 ;;^UTILITY(U,$J,358.3,24180,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24180,1,1,0)
 ;;=1^573.4
 ;;^UTILITY(U,$J,358.3,24180,1,2,0)
 ;;=2^HEPATIC INFARCTION
 ;;^UTILITY(U,$J,358.3,24180,2)
 ;;=^276862
 ;;^UTILITY(U,$J,358.3,24181,0)
 ;;=570.^^133^1472^13
 ;;^UTILITY(U,$J,358.3,24181,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24181,1,1,0)
 ;;=1^570.
 ;;^UTILITY(U,$J,358.3,24181,1,2,0)
 ;;=2^HEPATIC NECROSIS,ACUTE
 ;;^UTILITY(U,$J,358.3,24181,2)
 ;;=^2603
 ;;^UTILITY(U,$J,358.3,24182,0)
 ;;=572.4^^133^1472^14
 ;;^UTILITY(U,$J,358.3,24182,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24182,1,1,0)
 ;;=1^572.4
 ;;^UTILITY(U,$J,358.3,24182,1,2,0)
 ;;=2^HEPATORENAL SYNDROME
 ;;^UTILITY(U,$J,358.3,24182,2)
 ;;=^56497
 ;;^UTILITY(U,$J,358.3,24183,0)
 ;;=557.9^^133^1472^15
 ;;^UTILITY(U,$J,358.3,24183,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24183,1,1,0)
 ;;=1^557.9
 ;;^UTILITY(U,$J,358.3,24183,1,2,0)
 ;;=2^INTEST ISCHEMIA & INFARCTION
 ;;^UTILITY(U,$J,358.3,24183,2)
 ;;=^270252
 ;;^UTILITY(U,$J,358.3,24184,0)
 ;;=577.0^^133^1472^18
 ;;^UTILITY(U,$J,358.3,24184,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24184,1,1,0)
 ;;=1^577.0
 ;;^UTILITY(U,$J,358.3,24184,1,2,0)
 ;;=2^PANCREATITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,24184,2)
 ;;=^2643
 ;;^UTILITY(U,$J,358.3,24185,0)
 ;;=567.9^^133^1472^19
 ;;^UTILITY(U,$J,358.3,24185,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24185,1,1,0)
 ;;=1^567.9
 ;;^UTILITY(U,$J,358.3,24185,1,2,0)
 ;;=2^PERITONITIS NOS
 ;;^UTILITY(U,$J,358.3,24185,2)
 ;;=^92323
 ;;^UTILITY(U,$J,358.3,24186,0)
 ;;=452.^^133^1472^20
 ;;^UTILITY(U,$J,358.3,24186,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24186,1,1,0)
 ;;=1^452.
 ;;^UTILITY(U,$J,358.3,24186,1,2,0)
 ;;=2^PORTAL VEIN THROMBOSIS
 ;;^UTILITY(U,$J,358.3,24186,2)
 ;;=^269815
 ;;^UTILITY(U,$J,358.3,24187,0)
 ;;=556.9^^133^1472^21
 ;;^UTILITY(U,$J,358.3,24187,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24187,1,1,0)
 ;;=1^556.9
 ;;^UTILITY(U,$J,358.3,24187,1,2,0)
 ;;=2^ULCERATIVE COLITIS,UNSPEC
 ;;^UTILITY(U,$J,358.3,24187,2)
 ;;=^26044
 ;;^UTILITY(U,$J,358.3,24188,0)
 ;;=569.9^^133^1472^16
 ;;^UTILITY(U,$J,358.3,24188,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24188,1,1,0)
 ;;=1^569.9
 ;;^UTILITY(U,$J,358.3,24188,1,2,0)
 ;;=2^INTESTINAL COND NEC
 ;;^UTILITY(U,$J,358.3,24188,2)
 ;;=^123842
 ;;^UTILITY(U,$J,358.3,24189,0)
 ;;=573.9^^133^1472^17
 ;;^UTILITY(U,$J,358.3,24189,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24189,1,1,0)
 ;;=1^573.9
 ;;^UTILITY(U,$J,358.3,24189,1,2,0)
 ;;=2^LIVER DISEASE NEC
 ;;^UTILITY(U,$J,358.3,24189,2)
 ;;=^123854
 ;;^UTILITY(U,$J,358.3,24190,0)
 ;;=580.9^^133^1473^1
 ;;^UTILITY(U,$J,358.3,24190,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24190,1,1,0)
 ;;=1^580.9
 ;;^UTILITY(U,$J,358.3,24190,1,2,0)
 ;;=2^ACUTE GLOMERULONEPHRITIS
 ;;^UTILITY(U,$J,358.3,24190,2)
 ;;=^270342
 ;;^UTILITY(U,$J,358.3,24191,0)
 ;;=584.9^^133^1473^2
 ;;^UTILITY(U,$J,358.3,24191,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24191,1,1,0)
 ;;=1^584.9
 ;;^UTILITY(U,$J,358.3,24191,1,2,0)
 ;;=2^ACUTE RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,24191,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,24192,0)
 ;;=582.9^^133^1473^3
 ;;^UTILITY(U,$J,358.3,24192,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24192,1,1,0)
 ;;=1^582.9
 ;;^UTILITY(U,$J,358.3,24192,1,2,0)
 ;;=2^CHRONIC GLOMERULONEPHRITIS
 ;;^UTILITY(U,$J,358.3,24192,2)
 ;;=^270351
 ;;^UTILITY(U,$J,358.3,24193,0)
 ;;=585.9^^133^1473^4
 ;;^UTILITY(U,$J,358.3,24193,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24193,1,1,0)
 ;;=1^585.9
 ;;^UTILITY(U,$J,358.3,24193,1,2,0)
 ;;=2^CHRONIC KIDNEY DISEASE
 ;;
 ;;$END ROU IBDEI1D7
